To examine the association between genetic alterations and OS, age (<65 and ≥65 years), sex, presence of lung or bone metastasis, pathological types, BRAF mutation, RAS mutations, RET or NTRK fusion genes, TERT promoter mutations, and TP53 alterations were compared via log-rank test. The gene discussed is BRAF; the disease is metastasis.